Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus
Shun Kaneko(Tokyo Medical and Dental University), Mamoru Watanabe(The University of Tokyo), Tomoyuki Tsunoda(Tokyo Medical and Dental University), Takaji Wakita(National Institute of Infectious Diseases), Miyako Murakawa(Tokyo Medical and Dental University), Mina Nakagawa(Tokyo Medical and Dental University), Sei Kakinuma(The University of Tokyo), Hiroko Nagata(Tokyo Medical and Dental University), Hironori Nishitsuji(Fujita Health University), Hiromitsu Nakauchi(University of Tsukuba), Masashi Iwamoto(Rockefeller University), Seishin Azuma(Tokyo Medical and Dental University), Akihide Kamiya(Tokai University), Koichi Watashi(Tokyo University of Science), Fukiko Kawai‐Kitahata(Tokyo Medical and Dental University), Yasuhiro Asahina(Tokyo Medical and Dental University), Sayuri Nitta(Tokyo Medical and Dental University), Kunitada Shimotohno(National Center for Global Health and Medicine), Yu Asano(Tokyo Medical and Dental University), Masato Miyoshi(Tokyo Medical and Dental University), Yasuhiro Itsui(Tokyo Medical and Dental University), Satoshi Otani(Tokyo Medical and Dental University), Saneyuki Ujino(Chiba Institute of Technology)
Cited by 50
Related Papers
The lipid droplet is an important organelle for hepatitis C virus production
|Nature Cell Biology|2007|1.2k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
|Proceedings of the National Academy of Sciences|2007|474
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
|The Lancet|2021|452
Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer
|The EMBO Journal|1999|423